{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:13:18Z","timestamp":1793679198634,"version":"4.5.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["ECSA-2024-003"],"award-info":[{"award-number":["ECSA-2024-003"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["227946 \/Z\/23\/Z"],"award-info":[{"award-number":["227946 \/Z\/23\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203930 \/B\/16\/Z"],"award-info":[{"award-number":["203930 \/B\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011272","name":"European Commission Seventh Framework Programme for Research and Technological Development Health","doi-asserted-by":"publisher","award":["279093"],"award-info":[{"award-number":["279093"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004162","name":"Meath Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ebiom.2026.106159","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T23:47:19Z","timestamp":1771372039000},"page":"106159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Systemic inflammation, delirium and clinical progression in mild-moderate Alzheimer disease"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1356-510X","authenticated-orcid":false,"given":"Adam H.","family":"Dyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Dolphin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padraic G.","family":"Fallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0616-2874","authenticated-orcid":false,"given":"Cliona","family":"O'Farrelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nollaig M.","family":"Bourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3721-0197","authenticated-orcid":false,"given":"Sean P.","family":"Kennelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2026.106159_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102257","article-title":"Circulating biomarkers of inflammaging and Alzheimer's disease to track age-related trajectories of dementia: can we develop a clinically relevant composite combination?","volume":"96","author":"Abbatecola","year":"2024","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-023-00627-2","article-title":"The role of peripheral inflammatory insults in Alzheimer's disease: a review and research roadmap","volume":"18","author":"Walker","year":"2023","journal-title":"Mol Neurodegener"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106159_bib3","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/jgs.12994","article-title":"Long-term systemic inflammation and cognitive impairment in a population-based cohort","volume":"62","author":"Wichmann","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106159_bib4","doi-asserted-by":"crossref","first-page":"e1256","DOI":"10.1212\/WNL.0000000000007094","article-title":"Systemic inflammation during midlife and cognitive change over 20 years: the ARIC Study","volume":"92","author":"Walker","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2026.106159_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbi.2022.05.006","article-title":"Causal effects of circulating cytokine concentrations on risk of Alzheimer's disease and cognitive function","volume":"104","author":"Pagoni","year":"2022","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.ebiom.2026.106159_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2022.105870","article-title":"Peripheral inflammation marker relationships to cognition in healthy older adults - a systematic review","volume":"144","author":"Fard","year":"2022","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106159_bib7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","article-title":"Inflammatory proteins in plasma and the risk of dementia: the rotterdam study","volume":"61","author":"Engelhart","year":"2004","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106159_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","article-title":"Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview","volume":"50","author":"Brosseron","year":"2014","journal-title":"Mol Neurobiol"},{"issue":"20","key":"10.1016\/j.ebiom.2026.106159_bib9","doi-asserted-by":"crossref","first-page":"e2294","DOI":"10.1212\/WNL.0000000000201116","article-title":"Association of midlife inflammatory markers with cognitive performance at 10-Year Follow-up","volume":"99","author":"Kipinoinen","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2026.106159_bib10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neurobiolaging.2023.11.008","article-title":"Low-Grade systemic inflammation is associated with domain-specific cognitive performance and cognitive decline in older adults: data from the TUDA study","volume":"134","author":"Dyer","year":"2024","journal-title":"Neurobiol Aging"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106159_bib11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","article-title":"Inflammatory biomarkers in Alzheimer's disease plasma","volume":"15","author":"Morgan","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106159_bib12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib13","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41598-018-19807-y","article-title":"Plasma MCP-1 and cognitive decline in patients with Alzheimer's disease and mild cognitive impairment: a two-year Follow-up study","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106159_bib14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/alz.12399","article-title":"Plasma IL-12\/IFN-\u03b3 axis predicts cognitive trajectories in cognitively unimpaired older adults","volume":"18","author":"Yang","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106159_bib15","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106159_bib16","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/alz.13485","article-title":"Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK-ADRC cohort","volume":"20","author":"Foley","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106159_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13195-024-01513-9","article-title":"Diagnostic performance of plasma pTau(217), pTau(181), A\u03b2(1-42) and A\u03b2(1-40) in the LUMIPULSE automated platform for the detection of Alzheimer disease","volume":"16","author":"Arranz","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106159_bib19","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1093\/brain\/awaa286","article-title":"Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease","volume":"143","author":"Mattsson-Carlgren","year":"2020","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106159_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/d41573-023-00083-z","article-title":"NfL makes regulatory debut as neurodegenerative disease biomarker","volume":"22","author":"Mullard","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106159_bib21","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/acn3.51670","article-title":"Comparison of plasma and CSF biomarkers in predicting cognitive decline","volume":"9","author":"Aschenbrenner","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106159_bib22","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/brain\/awaa098","article-title":"Neurofilaments: neurobiological foundations for biomarker applications","volume":"143","author":"Gafson","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13024-023-00647-y","article-title":"Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer's disease with multi-modal PET and plasma GFAP","volume":"18","author":"Chiotis","year":"2023","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","article-title":"Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106159_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cells12091309","article-title":"GFAP as a potential biomarker for Alzheimer's disease: a systematic review and meta-analysis","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106159_bib27","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer's disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106159_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70535","article-title":"Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings","volume":"21","author":"Palmqvist","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106159_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70319","article-title":"Repeated plasma p-tau217 measurements to monitor clinical progression heterogeneity","volume":"21","author":"Kirsebom","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"18","key":"10.1016\/j.ebiom.2026.106159_bib30","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1039\/C5AN01238D","article-title":"Single molecule array (Simoa) assay with optimal antibody pairs for cytokine detection in human serum samples","volume":"140","author":"Wu","year":"2015","journal-title":"Analyst"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106159_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110989","article-title":"Early IFN\u03b2 secretion determines variable downstream IL-12p70 responses upon TLR4 activation","volume":"39","author":"Posseme","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2026.106159_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1178172","article-title":"Targeting the chemokine receptor CXCR4 with histamine analog to reduce inflammation in juvenile arthritis","volume":"14","author":"Bekaddour","year":"2023","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106159_bib33","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/alz.12341","article-title":"Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: Il-1\u03b2 drives amplified responses in primed astrocytes and neuronal network dysfunction","volume":"17","author":"Lopez-Rodriguez","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"40","key":"10.1016\/j.ebiom.2026.106159_bib34","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.1523\/JNEUROSCI.2614-05.2005","article-title":"Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration","volume":"25","author":"Cunningham","year":"2005","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106159_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.biopsych.2008.07.024","article-title":"Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease","volume":"65","author":"Cunningham","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.trci.2019.09.001","article-title":"A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy","volume":"5","author":"Torvell","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbr.2012.01.010","article-title":"Prolonged elevation in hippocampal A\u03b2 and cognitive deficits following repeated endotoxin exposure in the mouse","volume":"229","author":"Kahn","year":"2012","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-160673","article-title":"Acceleration of amyloidosis by inflammation in the amyloid-beta marmoset monkey model of Alzheimer's disease","volume":"55","author":"Philippens","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106159_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006364","article-title":"NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease","volume":"4","author":"Lawlor","year":"2014","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106159_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002660","article-title":"Nilvadipine in mild to moderate Alzheimer disease: a randomised controlled trial","volume":"15","author":"Lawlor","year":"2018","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106159_bib41","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106159_bib42","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archpsyc.1983.01790060110016","article-title":"The mini-mental state examination","volume":"40","author":"Folstein","year":"1983","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000521288","article-title":"Charlson comorbidity index: a critical review of clinimetric properties","volume":"91","author":"Charlson","year":"2022","journal-title":"Psychother Psychosom"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106159_bib45","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2026.106159_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S1041610297004870","article-title":"Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type","volume":"9","author":"Morris","year":"1997","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106159_bib47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5014\/ajot.53.5.471","article-title":"Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia","volume":"53","author":"G\u00e9linas","year":"1999","journal-title":"Am J Occup Ther"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106159_bib48","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/j.1532-5415.2012.04200.x","article-title":"Screening for delirium using family caregivers: convergent validity of the Family Confusion Assessment Method and interviewer-rated Confusion Assessment Method","volume":"60","author":"Steis","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106159_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011584","article-title":"European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow","volume":"6","author":"Meulenbroek","year":"2016","journal-title":"BMJ Open"},{"issue":"22","key":"10.1016\/j.ebiom.2026.106159_bib51","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1212\/01.wnl.0000263217.36439.da","article-title":"Inflammatory markers and the risk of Alzheimer disease: the Framingham Study","volume":"68","author":"Tan","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106159_bib52","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s43587-025-00816-2","article-title":"Interleukin-12 signaling drives Alzheimer's disease pathology through disrupting neuronal and oligodendrocyte homeostasis","volume":"5","author":"Schneeberger","year":"2025","journal-title":"Nature Aging"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12979-023-00397-x","article-title":"IL-17A promotes the progression of Alzheimer's disease in APP\/PS1 mice","volume":"20","author":"Cao","year":"2023","journal-title":"Immun Ageing"},{"key":"10.1016\/j.ebiom.2026.106159_bib54","article-title":"Senescence in aging and Alzheimer\u2019s disease","author":"Sun","year":"2025","journal-title":"Aging Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106159_bib55","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1038\/s41591-025-03798-1","article-title":"Plasma proteomics links brain and immune system aging with healthspan and longevity","volume":"31","author":"Oh","year":"2025","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13195-023-01254-1","article-title":"Blood and CSF chemokines in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis","volume":"15","author":"Zhou","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.ebiom.2026.106159_bib57","article-title":"Chemokines in patients with Alzheimer's disease: a meta-analysis","volume":"15","author":"Wang","year":"2023","journal-title":"Front Aging Neurosci"},{"issue":"Suppl 2","key":"10.1016\/j.ebiom.2026.106159_bib58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13054-016-1208-6","article-title":"36th international symposium on intensive care and emergency medicine: brussels, Belgium. 15-18 March 2016","volume":"20","author":"Bateman","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.ebiom.2026.106159_bib59","article-title":"Circulating Interleukin-17A is associated with executive function in middle aged adults with and without type 2 diabetes","volume":"41","author":"Morrison","year":"2024","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.ebiom.2026.106159_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1170012","article-title":"Characterisation of the pro-inflammatory cytokine signature in severe COVID-19","volume":"14","author":"Hawerkamp","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib61","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13195-024-01555-z","article-title":"Performance of plasma p-tau217 for the detection of amyloid-\u03b2 positivity in a memory clinic cohort using an electrochemiluminescence immunoassay","volume":"16","author":"Dyer","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106159_bib62","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/gerona\/61.6.575","article-title":"Interleukin-6 in aging and chronic disease: a magnificent pathway","volume":"61","author":"Maggio","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106159_bib63","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","article-title":"Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies","volume":"88","author":"Lai","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106159_bib64","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1002\/alz.13770","article-title":"Minimal clinically important difference in Alzheimer's disease: rapid review","volume":"20","author":"Muir","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106159_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14283\/jpad.2022.102","article-title":"Establishing clinically meaningful change on outcome assessments frequently used in trials of mild cognitive impairment due to Alzheimer's disease","volume":"10","author":"Lansdall","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106159_bib66","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213676","article-title":"Associations between changes in levels of phosphorylated tau and severity of cognitive impairment in early alzheimer disease","volume":"104","author":"Gonzalez-Ortiz","year":"2025","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2026.106159_bib67","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brainresrev.2009.11.004","article-title":"Neuroglia in neurodegeneration","volume":"63","author":"Heneka","year":"2010","journal-title":"Brain Res Rev"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106159_bib68","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106159_bib69","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","article-title":"Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer's disease","volume":"29","author":"Bellaver","year":"2023","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106159_bib70","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the alzheimer disease continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106159_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70626","article-title":"Moderating effects of plasma glial fibrillary acidic protein along the Alzheimer's disease continuum","volume":"21","author":"Lee","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106159_bib72","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/archneurol.2009.55","article-title":"Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type","volume":"66","author":"Snider","year":"2009","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106159_bib73","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e3181af79fb","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"issue":"Pt 9","key":"10.1016\/j.ebiom.2026.106159_bib74","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1093\/brain\/aws190","article-title":"Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study","volume":"135","author":"Davis","year":"2012","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106159_bib75","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ageing\/afaa244","article-title":"Recurrent delirium over 12 months predicts dementia: results of the Delirium and Cognitive Impact in Dementia (DECIDE) study","volume":"50","author":"Richardson","year":"2021","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106159_bib76","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/jamapsychiatry.2016.3423","article-title":"Association of delirium with cognitive decline in late life: a neuropathologic study of 3 population-based cohort studies","volume":"74","author":"Davis","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106159_bib77","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/gps.5088","article-title":"Delirium and Alzheimer disease: a proposed model for shared pathophysiology","volume":"34","author":"Fong","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106159_bib78","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.14283\/jpad.2024.112","article-title":"Clinical meaningfulness in Alzheimer's disease clinical trials. A report from the EU-US CTAD task force","volume":"11","author":"Angioni","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106159_bib79","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1002\/alz.14050","article-title":"Care partner-informed meaningful change thresholds for the Clinical Dementia Rating-Sum of Boxes for trials of early Alzheimer's disease","volume":"20","author":"Lansdall","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106159_bib80","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1474-4422(23)00447-7","article-title":"European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders","volume":"23","author":"Frisoni","year":"2024","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106159_bib81","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afae005","article-title":"New horizons in the diagnosis and management of Alzheimer's disease in older adults","volume":"53","author":"Dolphin","year":"2024","journal-title":"Age Ageing"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106159_bib82","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2019.2000","article-title":"Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia","volume":"321","author":"Rabinovici","year":"2019","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106159_bib83","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jalz.2015.06.1893","article-title":"Phase 3 solanezumab trials: secondary outcomes in mild Alzheimer's disease patients","volume":"12","author":"Siemers","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2026.106159_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.157033","article-title":"Long-term storage stability of plasma TNF-\u03b1 and IL-6 concentrations of psychiatric emergency patients: the Signature Biobank","volume":"196","author":"Cipriani","year":"2025","journal-title":"Cytokine"},{"issue":"4\u20135","key":"10.1016\/j.ebiom.2026.106159_bib85","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.clinbiochem.2009.11.004","article-title":"The use of a cytokine panel to define the long-term risk stratification of heart failure\/death in patients presenting with chest pain to the emergency department","volume":"43","author":"Kavsak","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ebiom.2026.106159_bib86","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ebiom.2016.08.038","article-title":"Effects of long-term storage time and original sampling month on biobank plasma protein concentrations","volume":"12","author":"Enroth","year":"2016","journal-title":"eBioMedicine"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642600040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642600040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:16:16Z","timestamp":1774512976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642600040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":84,"alternative-id":["S235239642600040X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106159","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic inflammation, delirium and clinical progression in mild-moderate Alzheimer disease","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106159"}}